Purchases and Sales Made in Q4 2022 in Anebulo Pharmaceuticals, Inc. (ANEB)
This table provides information about the institutional ownership of Anebulo Pharmaceuticals, Inc. (ANEB) during Q4 2022. The information is specifically focused on institutions that hold shares of Anebulo Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2023
Q4 2022
|
Praetorian Capital Management LLC
Coral Gables, FL |
BUY
|
- |
180KNew |
$322K - $610K
|
180K
$292K
|
|
Feb 08, 2023
Q4 2022
|
Herr Investment Group LLC
Austin, TX |
BUY
|
- |
29.6KNew |
$53.1K - $100K
|
29.6K
$48K
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
160+ 2.24% |
$286 - $542
|
7.29K
$11.8K
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
17+ 45.95% |
$30.4 - $57.6
|
54
$87.5
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Jan 18, 2023
Q4 2022
|
Lvw Advisors, LLC
|
SELL
|
- |
-1.05K- 0.16% |
$1.88K - $3.56K
|
674K
$1.09M
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-1.09K- 39.01% |
$1.94K - $3.68K
|
1.7K
$2.75K
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-3.73K- 50.93% |
$6.68K - $12.7K
|
3.6K
$5.83K
|